Congratulations to Bleck Design Group client Xagenic on receiving the 2014 North America Frost & Sullivan Award for New Product Innovation Leadership for the Xagenic X1™ system. The Xagenic X1™ is a point-of-care platform that provides lab-free molecular diagnostic testing.
“Xagenic’s technology is comparable with the PCR technology’s performance in terms of specificity and sensitivity, and outperforms it in speed, simplicity, size, ease of use, cost, and compatibility with an office setting,” said Frost & Sullivan Senior Industry Analyst Christi Bird. “It is ideal for a physician’s office setting, as it has a turnaround time of 15-20 minutes and cartridge pricing that allows for sufficient profit margin within existing US reimbursement and platform costs.”
The platform is in the beta-testing phase and expected to launch between 2015 and 2016.